CUONG V. DO - 21 Jun 2022 Form 4 Insider Report for BIOVIE INC. (BIVI)

Role
President & CEO, Director
Signature
/s/ Joanne Wendy Kim as Attorney-In-Fact
Issuer symbol
BIVI
Transactions as of
21 Jun 2022
Transactions value $
$0
Form type
4
Filing time
07 Jul 2022, 16:01:04 UTC
Previous filing
25 Jan 2022
Next filing
18 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIVI Stock Option (right to buy) Award $0 +125K $0.00 125K 21 Jun 2022 Common Stock 125K $1.69 See Footnote F1, F2, F3
transaction BIVI Restricted Stock Unit Award $0 +125K $0.00 125K 21 Jun 2022 Common Stock 125K See Footnote F1, F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted pursuant to the Company's 2019 Omnibus Equity Incentive Plan. Options granted by Compensation Committee on June 21, 2022.
F2 The options vest over a three-year period on each anniversary of the grant date.
F3 Securities are held in the name of Do & Rickles Investments LLC.
F4 Each restricted stock unit represents a contingent right to receive one share of the issuer's Class A common stock.
F5 The restricted stock units vest ratably over a three-year period on each anniversary of the grant date.